Big Gain For INmune Bio, Inc.
Tue, Jul 14, 2020 at 05:30 PM
INmune Bio, Inc. (INMB:NASDAQ) rocketted at $15.75, a gain of 78%. On Mon 13 Jul 20, INMB:NASDAQ hit a New 2-Week High of $8.85. The stock got featured on our News Catalysts scanner on Tue 14 Jul 20 at 03:17 PM in the 'BIOTECH' category. From Mon 29 Jun 20, the stock recorded 55.56% Up Days and 40.00% Green Days
About INmune Bio, Inc. (INMB:NASDAQ)
INmune Bio Inc is a clinical stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow the immune system to fight cancer. The company's products include INKmune, INB03, and others.
Top 10 Gainers:
- Perceptron, Inc. (PRCP:NASDAQ), 107.01%
- Rigel Pharmaceuticals, Inc. (RIGL:NASDAQ), 90.97%
- INmune Bio, Inc. (INMB:NASDAQ), 77.97%
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 57.21%
- IMV Inc. (IMV:NASDAQ), 54.33%
- Dare Bioscience, Inc. (DARE:NASDAQ), 50.5%
- Vaxart, Inc. (VXRT:NASDAQ), 40.02%
- Caladrius Biosciences, Inc. (CLBS:NASDAQ), 38.89%
- Iconix Brand Group, Inc. (ICON:NASDAQ), 33.33%
- VIVUS, Inc. (VVUS:NASDAQ), 32.45%